Literature DB >> 11058975

Factors that influence a patient's decision to participate in a phase I cancer clinical trial.

K M Schutta1, C B Burnett.   

Abstract

PURPOSE/
OBJECTIVES: To explore factors that influence an individual's decision to participate in phase I cancer clinical trials.
DESIGN: Exploratory, descriptive, and qualitative study.
SETTING: Outpatient oncology clinic of a comprehensive cancer center in an urban setting. SAMPLE: 22 patients with cancer who had been asked at some point during their treatment to participate in a phase I cancer clinical trial were invited to participate in a focus group. Eight patients participated.
METHODS: Two focus groups were conducted. MAIN RESEARCH VARIABLES: Factors that influenced patients' decisions to participate in a phase I cancer clinical trial.
FINDINGS: Participants expressed that hope for a cure and trusting the oncologist's advice were the primary factors that influenced their decisions to participate in phase I research. The majority expressed surprise that anyone would participate in an experimental study for altruistic reasons.
CONCLUSIONS: Patients choose to hope for some personal benefit from their participation in phase I clinical trials even though they realized that is not the purpose or goal of the trial. IMPLICATIONS FOR NURSING PRACTICE: Nurses are in an ideal position to offer information to individuals who are deciding whether to participate in a phase I cancer clinical trial. However, most nurses are not seizing this opportunity. Patients are unable to describe nurses' impact on their decision to enter a phase I cancer clinical trial.

Entities:  

Mesh:

Year:  2000        PMID: 11058975

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  21 in total

Review 1.  Communication and informed consent in phase 1 trials: a review of the literature.

Authors:  A C Cox; L J Fallowfield; V A Jenkins
Journal:  Support Care Cancer       Date:  2006-01-28       Impact factor: 3.603

2.  Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.

Authors:  Flavia M Facio; Stephanie Brooks; Johanna Loewenstein; Susannah Green; Leslie G Biesecker; Barbara B Biesecker
Journal:  Eur J Hum Genet       Date:  2011-07-06       Impact factor: 4.246

3.  The Role of Oncology Nurses in Discussing Clinical Trials.

Authors:  Susan A Flocke; Elizabeth Antognoli; Barbara J Daly; Brigid Jackson; Sarah E Fulton; Tasnuva M Liu; Jessica Surdam; Sharon Manne; Neal J Meropol
Journal:  Oncol Nurs Forum       Date:  2017-09-01       Impact factor: 2.172

4.  The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.

Authors:  Daniel P Sulmasy; Alan B Astrow; M Kai He; Damon M Seils; Neal J Meropol; Ellyn Micco; Kevin P Weinfurt
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

5.  Enrolling Genomics Research Participants through a Clinical Setting: the Impact of Existing Clinical Relationships on Informed Consent and Expectations for Return of Research Results.

Authors:  Courtney Berrios; Cynthia A James; Karen Raraigh; Juli Bollinger; Brittney Murray; Crystal Tichnell; Carolyn D Applegate; Amanda L Bergner
Journal:  J Genet Couns       Date:  2017-09-20       Impact factor: 2.537

Review 6.  Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.

Authors:  Jennifer A H Bell; Lynda G Balneaves
Journal:  Support Care Cancer       Date:  2015-01-17       Impact factor: 3.603

7.  Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations.

Authors:  Ricardo J Wray; Jo Ellen Stryker; Eric Winer; George Demetri; Karen M Emmons
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

8.  What leads Indians to participate in clinical trials? A meta-analysis of qualitative studies.

Authors:  Jatin Y Shah; Amruta Phadtare; Dimple Rajgor; Meenakshi Vaghasia; Shreyasee Pradhan; Hilary Zelko; Ricardo Pietrobon
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?

Authors:  Nancy Kass; Holly Taylor; Linda Fogarty; Jeremy Sugarman; Steven N Goodman; Annallys Goodwin-Landher; Michael Carducci; Herbert Hurwitz
Journal:  J Empir Res Hum Res Ethics       Date:  2008-09       Impact factor: 1.742

10.  Engaging patients and caregivers in patient-centered outcomes research on advanced stage lung cancer: insights from patients, caregivers, and providers.

Authors:  K M Islam; Samuel T Opoku; Bettye A Apenteng; Ann Fetrick; June Ryan; M Copur; Addison Tolentino; Irfan Vaziri; Apar K Ganti
Journal:  J Cancer Educ       Date:  2014-12       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.